Cefazolin prophylaxis in spine surgery: patients are frequently underdosed and at increased risk for infection

被引:5
|
作者
Karamian, Brian A. [1 ]
Toci, Gregory R. [1 ]
Lambrechts, Mark J. [1 ]
Siegel, Nicholas [1 ]
Sherman, Matthew [1 ]
Canseco, Jose A. [1 ]
Hilibrand, Alan S. [1 ]
Kepler, Christopher K. [1 ]
Vaccaro, Alexander R. [1 ]
Schroeder, Gregory D. [1 ]
机构
[1] Thomas Jefferson Univ, Rothman Inst, Dept Orthopaed Surg, Philadelphia, PA 19107 USA
来源
SPINE JOURNAL | 2022年 / 22卷 / 09期
关键词
Cefazolin; Cervical; Clinical outcomes; Dosing by weight; Infection rate; Lumbar; Perioperative antibiotics; Spine surgery; Surgical site infection; SURGICAL SITE INFECTION; BODY-MASS INDEX; INTRAWOUND VANCOMYCIN POWDER; ANTIBIOTIC-PROPHYLAXIS; LUMBAR FUSION; PREVENTION; GUIDELINE; EFFICACY;
D O I
10.1016/j.spinee.2022.05.018
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND CONTEXT: Perioperative antibiotics are critical in reducing the risk of postoperative spine infections. However, the efficacy and optimal weight-based prophylactic cefazolin dosing is unclear. PURPOSE: To determine (1) if inadequate weight-based prophylactic dosing of cefazolin affects infection rates after spinal fusions, and (2) identify the optimal dosing of cefazolin. STUDY DESIGN/SETTING: Single center retrospective cohort PATIENT SAMPLE: Patients undergoing posterior cervical or lumbar spinal fusion between January 2000 and October 2020 OUTCOME MEASURES: Postoperative surgical site infection status METHODS: Patients were grouped based on our institutionally derived dosing adequacy standards, 1 g for < 60 kg, 2 g for 60 to 120 kg, and 3 g for > 120 kg. Univariate comparisons and multivariate regressions identified the effect of inadequate dosing on infection rate. Patients were subsequently regrouped into cefazolin dose (grams) administered and logistic regression and receiver operating characteristic curves were compiled to determine the probability of infection based on cefazolin dose and patient weight. Alpha was set at 0.05. RESULTS: A total of 2,643 patients met inclusion criteria and 95 infections (3.6%) were identified. The infection rate was higher in the inadequate dosing group (5.86% vs. 2.58%, p<. 001). Adequate dosing was a predictor of decreased infections after lumbar fusion (OR: 0.43, p<.001), but not posterior cervical fusions (OR: 0.47, p=.065). Patients were subsequently regrouped into 1 g or 2 g of cefazolin administered resulting in a 5.01% and 2.77% infection rate, respectively (p=.005). The area under the curve (AUC) and 95% confidence interval for one (0.850 [0.777-0.924]) and two (0.575 [0.493-0.657]) g of cefazolin demonstrated lower infection rates for patients given 2 g cefazolin. CONCLUSIONS: Patients receiving an inadequate weight-based dose of preoperative cefazolin had an increased risk of infection following spinal fusion surgery. Two grams prophylactic cefazolin significantly reduces the likelihood of infection. (C) 2022 Elsevier Inc. All rights reserved.
引用
收藏
页码:1442 / 1450
页数:9
相关论文
共 50 条
  • [1] Cefazolin Prophylaxis for Total Joint Arthroplasty: Obese Patients Are Frequently Underdosed and at Increased Risk of Periprosthetic Joint Infection
    Rondon, Alexander J.
    Kheir, Michael M.
    Tan, Timothy L.
    Shohat, Noam
    Greenky, Max R.
    Parvizi, Javad
    JOURNAL OF ARTHROPLASTY, 2018, 33 (11): : 3551 - 3554
  • [2] Antibiotic prophylaxis in high-risk pediatric spine surgery: Is cefazolin enough?
    Piantoni, Lucas
    Tello, Carlos A.
    Remondino, Rodrigo G.
    Wilson, Ida A. Francheri
    Galaretto, Eduardo
    Bersusky, Ernesto S.
    Noel, Mariano A.
    SPINE DEFORMITY, 2020, 8 (04) : 669 - 676
  • [3] Antibiotic prophylaxis in high-risk pediatric spine surgery: Is cefazolin enough?
    Lucas Piantoni
    Carlos A. Tello
    Rodrigo G. Remondino
    Ida A. Francheri Wilson
    Eduardo Galaretto
    Ernesto S. Bersusky
    Mariano A. Noel
    Spine Deformity, 2020, 8 : 669 - 676
  • [4] IN PATIENTS WITH POST-OPERATIVE VENOUS THROMBOEMBOLIC EVENTS, PHARMACOLOGIC PROPHYLAXIS IS FREQUENTLY UNDERDOSED
    Unnikrishnan, Raman
    Cohen, Benjamin
    Ponziano, Michelle
    Krishnamurthi, Venkatesh
    JOURNAL OF UROLOGY, 2015, 193 (04): : E107 - E107
  • [5] COMPARISON OF CEFUROXIME AND CEFAZOLIN - PROPHYLAXIS AGAINST INFECTION IN ARTERIAL RECONSTRUCTIVE SURGERY
    BORRERO, E
    ROSENTHAL, D
    VASCULAR SURGERY, 1991, 25 (01): : 54 - 59
  • [6] Are changes in antibiotic prophylaxis recommendations responsible for an increased risk of cefazolin allergy?
    Cheron, Nicolas
    de Chaisemartin, Luc
    Aubert, Simon
    Laborier, Felix
    Montravers, Philippe
    Neukirch, Catherine
    Gouel-Cheron, Aurelie
    ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 2024, 43 (02)
  • [7] Is blood transfusion associated with an increased risk of infection among spine surgery patients? A meta-analysis
    He, Yu-Kun
    Li, Hui-Zi
    Lu, Hua-Ding
    MEDICINE, 2019, 98 (28)
  • [8] Metronidazole and cefazolin vs cefazolin alone for surgical site infection prophylaxis in gynecologic surgery at a comprehensive cancer center
    Knisely, Anne
    Iniesta, Maria D.
    Marten, Claire A.
    Chisholm, Gary
    Schmeler, Kathleen M.
    Taylor, Jolyn S.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2024, 231 (03) : e1 - e13
  • [9] The Impact of Cefazolin Shortage on Surgical Site Infection Following Spine Surgery in Japan
    Nakarai, Hiroyuki
    Yamada, Koji
    Tonosu, Juichi
    Abe, Hiroaki
    Watanabe, Kenichi
    Yoshida, Yuichi
    Ohya, Junichi
    Sato, Yusuke
    Hara, Nobuhiro
    Okazaki, Rentaro
    Azuma, Seiichi
    Nakamoto, Hideki
    Kato, So
    Oshima, Yasushi
    Tanaka, Sakae
    Higashikawa, Akiro
    SPINE, 2021, 46 (14) : 923 - 930
  • [10] Intrawound Vancomycin powder as the prophylaxis of surgical site infection after invasive spine surgery with a high risk of infection
    Hida, Tetsuro
    Ando, Kei
    Kobayashi, Kazuyoshi
    Ito, Kenyu
    Tsushima, Mikito
    Matsumoto, Akiyuki
    Morozumi, Masayoshi
    Tanaka, Satoshi
    Machino, Masaaki
    Ota, Kyotaro
    Kanbara, Shunsuke
    Ito, Sadayuki
    Nishida, Yoshihiro
    Ishiguro, Naoki
    Imagama, Shiro
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2017, 79 (04): : 545 - 550